TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35074134

Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate umbilical cord clamping
Number of subjects: 0
Study: 32739569

Group type: EXPERIMENTAL
Intervention: Live phone call primer
Number of subjects: 2825

Group type: COMPARATOR
Intervention: Text message primer
Number of subjects: 2825
Study: 32525863

Group type: EXPERIMENTAL
Intervention: Energy-dense enteral nutrition (1.5kcal/mL)
Number of subjects: 1257

Group type: COMPARATOR
Intervention: Routine enteral nutrition (1kcal/mL)
Number of subjects: 1257
Study: 35801864

Group type: EXPERIMENTAL
Intervention: Six-Minute Walk Test
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Modified Bruce Treadmill Test
Number of subjects: 67
Study: 32501612

Group type: EXPERIMENTAL
Intervention: Treatment for type 2 diabetes (specific treatments not detailed)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Increase in HbA1c
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Increase in systolic blood pressure
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Increase in diastolic blood pressure
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Presence of microalbuminuria
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Retinopathy
Number of subjects: 515
Study: 35111219

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 36
Study: 33827832

Group type: EXPERIMENTAL
Intervention: Induction of labour at 41 weeks
Number of subjects: 2760

Group type: COMPARATOR
Intervention: Expectant management until 42 weeks
Number of subjects: 2760
Study: 32807214

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Streptomycin followed by ciprofloxacin
Number of subjects: 0
Study: 35113940

Group type: EXPERIMENTAL
Intervention: Group-based weight management programme for 12 weeks
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Group-based weight management programme for 52 weeks
Number of subjects: 739

Group type: COMPARATOR
Intervention: Self-help
Number of subjects: 739
Study: 32081633

Group type: EXPERIMENTAL
Intervention: Synthetic ligament (LockDown)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Coracoclavicular suspensory construct
Number of subjects: 14
Study: 615920668

Group type: EXPERIMENTAL
Intervention: FrACT visual acuity testing system
Number of subjects: 25

Group type: COMPARATOR
Intervention: ETDRS visual acuity testing system
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: FrACT and ETDRS during defocus testing
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: ETDRS (0.02 logMAR) and FrACT (0.03 logMAR)
Number of subjects: 25
Study: 35368961

Group type: EXPERIMENTAL
Intervention: Jiedu Pingsou Decoction combined with azithromycin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 68
Study: 34003667

Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg followed by 0.5 mg 1 hour later)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 75
Study: 32926841

Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2 intravenously every 3 weeks, 10 mg daily prednisone, and granulocyte colony-stimulating factor)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Abiraterone or Enzalutamide (1000 mg orally once daily plus 5 mg prednisone twice daily or 160 mg orally daily)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 255

Group type: COMPARATOR
Intervention: Abiraterone or Enzalutamide
Number of subjects: 255
Study: 35199913

Group type: EXPERIMENTAL
Intervention: Modified Singh's algorithm care bundle (MOSA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (professional judgments for decannulation)
Number of subjects: 22
Study: 32299585

Group type: EXPERIMENTAL
Intervention: Recent smokers
Number of subjects: 2564

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 2564
Study: 32715828

Group type: EXPERIMENTAL
Intervention: 2 iStent® trabecular micro-bypass stents
Number of subjects: 39
Study: 32223381

Group type: EXPERIMENTAL
Intervention: Intensive systolic BP-targets
Number of subjects: 13266

Group type: COMPARATOR
Intervention: Standard systolic BP-targets
Number of subjects: 13266
Study: 36154510

Group type: EXPERIMENTAL
Intervention: Energy healing
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 34023321

Group type: EXPERIMENTAL
Intervention: Systemic anticancer treatment (SACT)
Number of subjects: 280

Group type: COMPARATOR
Intervention: No systemic anticancer treatment (SACT)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Chemical pleurodesis
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Pharmacological sensitivity
Number of subjects: 280
Study: 35932165

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 88

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 88
Study: 32307286

Group type: EXPERIMENTAL
Intervention: Chitosan blood implant with microfracture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Microfracture alone
Number of subjects: 0
Study: 33443368

Group type: EXPERIMENTAL
Intervention: Low-load resistance training to failure (FAI)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Low-load resistance training to voluntary interruption (VOL)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Low-load resistance training with fixed low repetitions (FIX)
Number of subjects: 41
Study: 33446795

Group type: EXPERIMENTAL
Intervention: Inhaling coffee aroma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaling sham aroma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjective assessment using visual analog scale
Number of subjects: 0
Study: 34874061

Group type: EXPERIMENTAL
Intervention: ENABLE Cornerstone intervention (lay navigator-led telehealth sessions)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 63
Study: 33726840

Group type: EXPERIMENTAL
Intervention: Simulated 12-h night shift with total sleep deprivation
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Simulated 12-h night shift with a 30-min nap opportunity
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Simulated 12-h night shift with a 2-h nap opportunity
Number of subjects: 35
Study: 36114096

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel (100 mg/m² on days 1, 8, and 15 of a 21-day cycle)
Number of subjects: 503

Group type: COMPARATOR
Intervention: docetaxel (60 mg/m² on day 1)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel
Number of subjects: 503

Group type: COMPARATOR
Intervention: docetaxel
Number of subjects: 503
Study: 33657558

Group type: EXPERIMENTAL
Intervention: Early fitting group (EF, n = 67)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (CG, n = 60)
Number of subjects: 127
Study: 35331718

Group type: EXPERIMENTAL
Intervention: Active tDCS + exercising
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sham tDCS + exercising
Number of subjects: 120

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 120
Study: 33278181

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (VR)
Number of subjects: 60
Study: 35685671

Group type: EXPERIMENTAL
Intervention: CVVH combined with Xuebijing
Number of subjects: 100
Study: 33523488

Group type: EXPERIMENTAL
Intervention: Hospital-family holistic care intervention based on 'Timing It Right'
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (routine care and follow-up)
Number of subjects: 125
Study: 32796901

Group type: EXPERIMENTAL
Intervention: Optimized T7 promoter (CEL-Seq+)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T7 promoter variants with enhanced transcriptional output
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard T7 promoter (implied control)
Number of subjects: 0
Study: 35390339

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Nivolumab-ipilimumab
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: VEGFR-TKI
Number of subjects: 202

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 202
Study: 33608711

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 35627740

Group type: EXPERIMENTAL
Intervention: Nordic walking (aerobic exercise)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Dance (dual-task training with aerobic exercise)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88
Study: 35002970

Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg PO daily throughout hospitalization
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard of care therapy
Number of subjects: 64
Study: 35662590

Group type: EXPERIMENTAL
Intervention: Self-efficacy score (mean 3.01, SD = 0.49)
Number of subjects: 1078
Study: 32975391

Group type: EXPERIMENTAL
Intervention: Combined exercise training (CBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 20
Study: 32249034

Group type: EXPERIMENTAL
Intervention: SMART intervention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 105
Study: 35474759

Group type: EXPERIMENTAL
Intervention: Self-Help Plus (SH+) intervention for 1 month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving information about mental health promotion
Number of subjects: 0
Study: 33862565

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nasopore (Control)
Number of subjects: 50
Study: 35608826

Group type: EXPERIMENTAL
Intervention: Wearing a surgical mask (MASK) during HIIE
Number of subjects: 10

Group type: COMPARATOR
Intervention: Not wearing a surgical mask (CON) during HIIE
Number of subjects: 10
Study: 32696695

Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Blood Pressure (SMBP) with feedback to patient or provider
Number of subjects: 2590

Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Blood Pressure (SMBP) with telemonitoring or self-management
Number of subjects: 2590

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2590

Group type: EXPERIMENTAL
Intervention: Extended SMBP interventions for 5 years
Number of subjects: 2590

Group type: EXPERIMENTAL
Intervention: Extended SMBP with telemonitoring or self-management for 5 years
Number of subjects: 2590
Study: 36242089

Group type: EXPERIMENTAL
Intervention: Active-PEMF
Number of subjects: 118

Group type: COMPARATOR
Intervention: Inactive control (placebo)
Number of subjects: 118
Study: 35224710

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 µg/day)
Number of subjects: 60
Study: 34333803

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metformin 1 g twice daily
Number of subjects: 60
Study: 33713359

Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribociclib in combination with aromatase inhibitors or fulvestrant
Number of subjects: 0
Study: 32334615

Group type: EXPERIMENTAL
Intervention: Sonke CHANGE intervention delivered over 18 months, including community action activities such as door-to-door discussions and workshops.
Number of subjects: 2406

Group type: EXPERIMENTAL
Intervention: Sonke CHANGE intervention delivered over 18 months.
Number of subjects: 2406
Study: 35835944

Group type: EXPERIMENTAL
Intervention: VR-based intervention
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 54
Study: 33185897

Group type: EXPERIMENTAL
Intervention: RT+AT (Resistance Training + Aerobic Training)
Number of subjects: 40
Study: 32219762

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation over 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36000718

Group type: EXPERIMENTAL
Intervention: Adenosine (20 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 43
Study: 35766559

Group type: EXPERIMENTAL
Intervention: MCT-milk
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 45
Study: 32124732

Group type: EXPERIMENTAL
Intervention: GeoPain measures
Number of subjects: 125

Group type: COMPARATOR
Intervention: Visual Analog Scale (VAS)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Pain Area and Intensity Number Summation (PAINS)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: PAINS
Number of subjects: 125

Group type: COMPARATOR
Intervention: VAS
Number of subjects: 125
Study: 34383958

Group type: EXPERIMENTAL
Intervention: Ekso training
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lokomat training
Number of subjects: 6
Study: 32956867

Group type: EXPERIMENTAL
Intervention: 50 ppm Pb in drinking water for 36 days
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 500 ppm Pb in drinking water for 36 days
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 1000 ppm Pb in drinking water for 36 days
Number of subjects: 4

Group type: COMPARATOR
Intervention: 0 ppm Pb in drinking water for 36 days
Number of subjects: 4
Study: 35995105

Group type: EXPERIMENTAL
Intervention: 12-week tailored text message smoking-cessation program with a companion web-based intervention (n = 172)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Referral to online quit resources (usual care control; n = 171)
Number of subjects: 343
Study: 33407612

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n=12, BMI 34.55 ± 1.20)
Number of subjects: 20
Study: 35152509

Group type: EXPERIMENTAL
Intervention: OneShape rotary system (Micro‐Mega)
Number of subjects: 164

Group type: COMPARATOR
Intervention: WaveOne Gold reciprocating system (Dentsply Maillefer)
Number of subjects: 164
Study: 34717750

Group type: EXPERIMENTAL
Intervention: Video Intervention Therapy (VIT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 32993116

Group type: EXPERIMENTAL
Intervention: Gradually Reduced Nicotine Content (RNC) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Nicotine Content (UNC) group
Number of subjects: 0
Study: 35089964

Group type: EXPERIMENTAL
Intervention: Ringers lactate (RL)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 51
Study: 33449309

Group type: EXPERIMENTAL
Intervention: High intensity resistance training (HIRT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (inactive)
Number of subjects: 43
Study: 33858965

Group type: EXPERIMENTAL
Intervention: Industry‐proposed disclaimer
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Moonlight ads
Number of subjects: 807
Study: 32596783

Group type: EXPERIMENTAL
Intervention: S-1/oxaliplatin (SOX)
Number of subjects: 338

Group type: COMPARATOR
Intervention: S-1/cisplatin (SP3)
Number of subjects: 338
Study: 32971053

Group type: EXPERIMENTAL
Intervention: Community-based ART delivery
Number of subjects: 1315

Group type: EXPERIMENTAL
Intervention: Hybrid approach (clinic initiation + mobile van monitoring)
Number of subjects: 1315

Group type: EXPERIMENTAL
Intervention: Community-based ART delivery among men
Number of subjects: 1315

Group type: EXPERIMENTAL
Intervention: Hybrid approach among men
Number of subjects: 1315

Group type: COMPARATOR
Intervention: Clinic-based ART
Number of subjects: 1315
Study: 35564808

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo water (PW)
Number of subjects: 18
Study: 34161146

Group type: EXPERIMENTAL
Intervention: Flaxseed (40-g packets daily before and during radiotherapy)
Number of subjects: 33
Study: 33052401

Group type: EXPERIMENTAL
Intervention: Pembrolizumab-axitinib
Number of subjects: 100000

Group type: COMPARATOR
Intervention: Nivolumab-ipilimumab
Number of subjects: 100000
Study: 33766835

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 430

Group type: COMPARATOR
Intervention: Observation/conservative management (medical management)
Number of subjects: 430
Study: 32012190

Group type: EXPERIMENTAL
Intervention: CYP2R1/rs10741657 heterozygote carriage
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: GC/rs4588 heterozygote carriage
Number of subjects: 920

Group type: EXPERIMENTAL
Intervention: Carriage of two risk alleles (genetic risk score)
Number of subjects: 920
Study: 35232217

Group type: EXPERIMENTAL
Intervention: Screening with handheld single-lead ECG (AliveCor KardiaMobile) during vital sign assessments.
Number of subjects: 30715

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 30715
Study: 34255703

Group type: EXPERIMENTAL
Intervention: Mobile phone-based life-skills training program (SmartCoach) over 22 weeks
Number of subjects: 1473
Study: 32340248

Group type: EXPERIMENTAL
Intervention: Basal Fat Oxidation (BFox)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Basal Carbohydrate Oxidation (BCHox)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Basal Metabolic Rate (BMR)
Number of subjects: 71
Study: 35385425

Group type: EXPERIMENTAL
Intervention: VGH-BPH1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34499583

Group type: EXPERIMENTAL
Intervention: Vestibular/oculomotor rehabilitation protocol
Number of subjects: 27
Study: 32431299

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions
Number of subjects: 100
Study: 34478532

Group type: EXPERIMENTAL
Intervention: BST-Cargel after arthroscopic microfracture
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: PRP after arthroscopic microfracture
Number of subjects: 62

Group type: COMPARATOR
Intervention: Arthroscopic microfracture (MF)
Number of subjects: 62
Study: 35835755

Group type: EXPERIMENTAL
Intervention: Tenofovir (TFV) intravaginal ring
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tenofovir and levonorgestrel (TFV/LNG) intravaginal ring
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo intravaginal ring
Number of subjects: 27
Study: 34145796

Group type: EXPERIMENTAL
Intervention: Participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noneligible patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonconsenting patients
Number of subjects: 0
Study: 34699278

Group type: EXPERIMENTAL
Intervention: Head and neck melanoma (HNM)
Number of subjects: 39754

Group type: EXPERIMENTAL
Intervention: Melanoma of the scalp and neck (MSN)
Number of subjects: 39754
Study: 32499244

Group type: EXPERIMENTAL
Intervention: CRD (cyclophosphamide, lenalidomide, and dexamethasone)
Number of subjects: 2042

Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 2042

Group type: COMPARATOR
Intervention: CTD (cyclophosphamide, thalidomide, and dexamethasone)
Number of subjects: 2042

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 2042
Study: 32291974

Group type: EXPERIMENTAL
Intervention: Full endoscopic transforaminal decompression (FETD) under local anesthesia
Number of subjects: 63
Study: 36104059

Group type: EXPERIMENTAL
Intervention: ESPB (Erector Spinae Plane Block) with 20 mL of 0.25% bupivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no ESPB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ESPB
Number of subjects: 30
Study: 32619238

Group type: EXPERIMENTAL
Intervention: Investigator-initiated trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Industry-led trials
Number of subjects: 0
Study: 32578800

Group type: EXPERIMENTAL
Intervention: Electric Toothbrush (ET)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Manual Toothbrush (MT)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both toothbrush types
Number of subjects: 29
Study: 35712521

Group type: EXPERIMENTAL
Intervention: Sanyin formula (SYF) plus conventional standard chemotherapy
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo plus conventional standard chemotherapy
Number of subjects: 252
Study: 34404628

Group type: EXPERIMENTAL
Intervention: Training session for primary care workers based on the Brazilian National Guidelines for Children
Number of subjects: 715
Study: 36074816

Group type: EXPERIMENTAL
Intervention: Robotic-arm-assisted TKA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional jig-based TKA
Number of subjects: 30
Study: 32460116

Group type: EXPERIMENTAL
Intervention: Supervised group exercise (60 min, 2 times/week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 90
Study: 35838186

Group type: EXPERIMENTAL
Intervention: Active-fluidics system (AFS)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Gravity-fluidics system (GFS)
Number of subjects: 107
Study: 34606560

Group type: EXPERIMENTAL
Intervention: Borage oil (880 mg GLA per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Evening primrose oil (540 mg GLA per day)
Number of subjects: 0
Study: 36353999

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 4071

Group type: COMPARATOR
Intervention: Control (discontinue all antihypertensive medications)
Number of subjects: 4071
Study: 33987915

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Clinical‐laboratory model
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Radiomics‐clinical‐laboratory model
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Multipredictor nomogram
Number of subjects: 162
Study: 32838673

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure reduction (goal 110‐139 mm Hg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard systolic blood pressure reduction (goal 140‐179 mm Hg)
Number of subjects: 1000
Study: 35438442

Group type: EXPERIMENTAL
Intervention: eHealth Cognitive-Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 30
Study: 33439215

Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PRS) for depression
Number of subjects: 17098

Group type: EXPERIMENTAL
Intervention: Parental history of mood or psychotic disorders
Number of subjects: 17098

Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status (SES)
Number of subjects: 17098

Group type: COMPARATOR
Intervention: Combination of risk factors (high SES, low PRS)
Number of subjects: 17098

Group type: COMPARATOR
Intervention: Combination of risk factors (high PRS, parental history)
Number of subjects: 17098